Patient No. Vaccine brand Route Disease category S IFN-γ+ CD4 post-dose 2 (%) S IFN-γ+ CD8 post-dose 2 (%) SNM IFN-γ+ CD4 post-dose 2 (%) SNM IFN-γ+ CD8 post-dose 2 (%) S IFN-γ+ CD4 post-dose 3 (%) S IFN-γ+ CD8 post-dose 3 (%) SNM IFN-γ+ CD4 post-dose 3 (%) SNM IFN-γ+ CD8 post-dose 3 (%)
1 BB MM Dysregulation 0.014 0.0025 / / / / / /
2 BB MM Humoral 0.46 0.20 / / / / / /
3 BB MM Humoral 0.14 0.0025 / / / / / /
4 BB MM Innate 0.19 0.0025 / / / / / /
6 BBB MMD Combined 0.070 0.0025 / / 0.28 0.0025 / /
7 BBB MMD Dysregulation 0.0070 0.010 / / 0.0025 0.0025 / /
8 BBB MMD Humoral / / / / 0.12 0.0025 / /
9 BBB MMD Innate 0.0025 0.0090 / / 0.0050 0.041 / /
10 BBB MMM Combined 0.0025 0.0025 / / 0.083 0.010 / /
11 BBB MMM Combined 0.0025 0.048 / / / / / /
12 BBB MMM Dysregulation 0.13 0.0025 / / 0.299 0.0025 / /
13 BBB MMM Humoral 0.55 0.39 / / 0.19* 0.71* / /
14 BBB MMM Humoral 0.16 0.0025 / / 0.35 0.82 / /
15 BBB MMM Humoral 0.0025 0.0025 / / 0.19 0.0025 / /
16 BBB MMM Innate 0.0025 0.020 / / / / / /
17 BBB MMM Innate 0.098 0.0025 / / 0.0076 0.0060 / /
18 BBB MMM Phagocytic 0.0025 0.0025 / / 0.0025 0.0025 / /
19 BBB MMM Phagocytic 0.0025 0.0025 / / 0.0025 0.0025 / /
20 BBB MMM Phagocytic 0.0025 0.0025 / / 0.11 0.0025 / /
26 CCC DDD Combined 0.0025 0.0025 0.16 0.0075 0.32* 0.34* 1.0* 1.4*
29 CCC MMM Dysregulation 0.0025 0.0025 0.0075 0.0075 0.0025 0.0025 0.055 0.18
32 CCC MMM Humoral / / / / 0.017 0.090 / /
33 CCC MMM Humoral 0.15 0.0025 0.16 0.0075 0.0025 0.0025 0.0075 /
34 CCC MMM Humoral 0.0025 0.0025 0.0075 0.0075 0.16 0.36 0.37 1.0
35 CCC MMM Humoral 0.0025 0.0025 0.41 0.53 0.017 0.022 0.053 0.065
36 CCC MMM Humoral 0.77 0.23 1.4 0.45 0.0025 0.0025 0.31 0.0075
37 CCC MMM Humoral 0.0025 0.0025 0.033 0.0075 0.04 0.0025 0.31 0.0075
38 CCC MMM Phagocytic 0.0025 0.0025 0.0075 0.0075 0.0025 0.0025 0.0075 0.0075
39 CCC MMM Phagocytic 0.070 0.25 0.36 0.84 0.026 0.0025 0.060 0.0075